Oncology: Difference between revisions
No edit summary |
No edit summary |
||
| Line 15: | Line 15: | ||
<br> | <br> | ||
=== Mental | === Mental Function & Pain === | ||
Mental function can be affected by radiation and chemotherapy through the changes in the central nervous system<ref name="Breast Cancer Cognitive Dysfunction">Ahles T, Saykin A. Breast cancer chemotherapy-related cognitive dysfunction. Clin Breast Cancer.2002;3:S84–S90.</ref> <ref>Castellon S, Ganz P, Bower J, et al. Neurocognitive performance in breast cancer survivors exposed to adjuvant chemotherapy and tamoxifen. J Clin Exp Neuropsychol. 2004;26:955–969.</ref><ref>Stewart A, Bielajew C, Collins B, et al. A meta analysis of the neuropsychological effects of adjuvant chemotherapy treatment in women treated for breast cancer. Clin Neuropsychol. 2006;20:76–89.</ref> Mental impairments can be indusced by inflammation, destructive autoimmune responses, toxicity levels and oxidative damage<ref>Ahles T, Saykin A, Furstenberg C, et al. Neuropsychologic impact of standard dose systemic chemotherapy in longterm survivors of breast cancer and lymphoma.J Clin Oncol. 2002;20:485–493</ref>. Emotional Functions may alos affect the ability of our patients to respond to and/or participate in physical therapy. | Mental function can be affected by radiation and chemotherapy through the changes in the central nervous system<ref name="Breast Cancer Cognitive Dysfunction">Ahles T, Saykin A. Breast cancer chemotherapy-related cognitive dysfunction. Clin Breast Cancer.2002;3:S84–S90.</ref> <ref>Castellon S, Ganz P, Bower J, et al. Neurocognitive performance in breast cancer survivors exposed to adjuvant chemotherapy and tamoxifen. J Clin Exp Neuropsychol. 2004;26:955–969.</ref><ref>Stewart A, Bielajew C, Collins B, et al. A meta analysis of the neuropsychological effects of adjuvant chemotherapy treatment in women treated for breast cancer. Clin Neuropsychol. 2006;20:76–89.</ref> Mental impairments can be indusced by inflammation, destructive autoimmune responses, toxicity levels and oxidative damage<ref>Ahles T, Saykin A, Furstenberg C, et al. Neuropsychologic impact of standard dose systemic chemotherapy in longterm survivors of breast cancer and lymphoma.J Clin Oncol. 2002;20:485–493</ref>. Emotional Functions may alos affect the ability of our patients to respond to and/or participate in physical therapy. | ||
| Line 43: | Line 43: | ||
| | ||
===== Neurological Assessment Measures ===== | ===== Neurological Assessment Measures ===== | ||
====== Vestibular ====== | ====== Vestibular ====== | ||
| Line 65: | Line 65: | ||
3. Motor Function Loss | 3. Motor Function Loss | ||
Radiation Plexopathy | Radiation Plexopathy | ||
=== Neuromusculoskeletal Function (Movement Related Functional Assessment) === | |||
Posture | |||
ROM | |||
Strength | |||
Balance | |||
Gait | |||
=== System Screening === | |||
Cardiovascular | |||
Hematologic | |||
Immunologic | |||
Respiratory | |||
=== Red and Yellow Flag Measures === | |||
=== Functional Activities === | |||
=== Psychosocial === | |||
== Medical Management == | == Medical Management == | ||
Revision as of 17:48, 1 February 2013
Physiotherapy is an autonomous profession concerned with the care, management and rehabilitation of
patients. These principles apply to the management of patients with cancer through all care and
rehabilitation programmes from diagnosis to the end of life. Physiotherapists conduct ongoing assessment of the needs of this patient group and their carers, in order to apply skilled interventions, which are vital for patients’ independence, functional capacity and quality of life. The role of the physiotherapist, as an essential member of the multi-disciplinary team is key to the successful rehabilitation and management of patients with cancer and palliative care needs. The absence of physiotherapy intervention would be detrimental to patient care and the ability of the patient/family to cope with the effects of the disease or its treatment on their functional capacity and quality of life[1].
Physiology[edit | edit source]
Conditions[edit | edit source]
Examination[edit | edit source]
Using the International Classification Framework Model for Assessment in Oncology Rehabilitation[2][3]
by Gilchrist LS, Galantino ML, Wampler M, et al.
Mental Function & Pain[edit | edit source]
Mental function can be affected by radiation and chemotherapy through the changes in the central nervous system[4] [5][6] Mental impairments can be indusced by inflammation, destructive autoimmune responses, toxicity levels and oxidative damage[7]. Emotional Functions may alos affect the ability of our patients to respond to and/or participate in physical therapy.
Diagnostic & Screening Measures[edit | edit source]
Mental Status[edit | edit source]
The Mini-Mental State Examination[8]
read more about the Mini-Mental State Examination Measure & Link
Profile of Mood States[9]
read more about the POMS
Pain Assessment[edit | edit source]
1. Visual Analog Scale
2. Numeric Rating Scale
3. Faces Pain Scale
Neurological Assessment Measures[edit | edit source]
Vestibular[edit | edit source]
May be affected by neoplasms such as a Vestibular schwannoma which may cause unilateral dysfunction or chemotherapy drugs such as Cisplastin
Dizziness Handicap Inventory Questionnaire--25 items assess the impact of disequilibrium on functional activities.[11]
Somatosensory[edit | edit source]
Neuromusculoskeletal[edit | edit source]
1. Peripheral Neuropathies--Chemotherapy induced
modified Total Neuropathy Score[12][13]
2. Anesthesia/Dysestheis
with compression or surgical dissection of nerves
3. Motor Function Loss
Radiation Plexopathy
Neuromusculoskeletal Function (Movement Related Functional Assessment)[edit | edit source]
Posture
ROM
Strength
Balance
Gait
System Screening[edit | edit source]
Cardiovascular
Hematologic
Immunologic
Respiratory
Red and Yellow Flag Measures[edit | edit source]
Functional Activities[edit | edit source]
Psychosocial[edit | edit source]
Medical Management[edit | edit source]
Physiotherapy Intervention[edit | edit source]
Outcome Measures[edit | edit source]
Recent Research from Physiospot[edit | edit source]
References[edit | edit source]
- ↑ The Role of Physiotherapy for People with Cancer - CSP Position Statement. The Chartered Society of Physiotherapy, July 2003. Available at http://www.csp.org.uk/uploads/documents/csp_statement_physioandcancer.pdf. Retrieved 10/7/2010
- ↑ International Classification of Functioning, Disability and Health: ICF. Geneva,Switzerland: World Health Organization; 2001
- ↑ Gilchrist LS, Galantino ML, Wampler M, et al. A Framework for Assessment in Oncology Rehabilitation. Physical Therapy . 89 (3 ):286–306. Available at: http://ptjournal.apta.org/content/89/3/286.abstract.
- ↑ Ahles T, Saykin A. Breast cancer chemotherapy-related cognitive dysfunction. Clin Breast Cancer.2002;3:S84–S90.
- ↑ Castellon S, Ganz P, Bower J, et al. Neurocognitive performance in breast cancer survivors exposed to adjuvant chemotherapy and tamoxifen. J Clin Exp Neuropsychol. 2004;26:955–969.
- ↑ Stewart A, Bielajew C, Collins B, et al. A meta analysis of the neuropsychological effects of adjuvant chemotherapy treatment in women treated for breast cancer. Clin Neuropsychol. 2006;20:76–89.
- ↑ Ahles T, Saykin A, Furstenberg C, et al. Neuropsychologic impact of standard dose systemic chemotherapy in longterm survivors of breast cancer and lymphoma.J Clin Oncol. 2002;20:485–493
- ↑ Folstein M, Folstein S, McHugh P. Mini-Mental State: a practical method for grading the state of patients for the clinician J Psychiatr Res. 1975;12:189–198.
- ↑ Cella D, Tross S, Orov E, et al. Mood states of patients after the diagnosis of cancer. J Psychosoc Oncol. 1989;7:45–53.
- ↑ Cleeland C. Measurement and prevalence of pain in cancer. Semin Oncol Nurs. 1985;1:87–92.
- ↑ Jacobson G, Newman C, Hunter L, Balzer G. Balance function test correlates of the Dizziness Handicap Inventory. J Am Acad Audiol. 1991;2:253–260.
- ↑ Cavaletti G, Bogliun G, Marzorati L, et al. Grading of chemotherapy-induced peripheral neurotoxicity using the Total Neuropathy Scale. Neurology. 2003;61:fckLR1297–1300.
- ↑ Wampler, Meredith A., et al. "The modified Total Neuropathy Score: a clinically feasible and valid measure of taxane-induced peripheral neuropathy in women with breast cancer." J Support Oncol 2006; 4.8:W9-W16.
